Mannkind (MNKD) Debt Ratio (2010 - 2026)
Mannkind (MNKD) reported Debt Ratio of 0.14 for Q1 2026, down 45.21% year-over-year from 0.25 in Q1 2025, and up 6.18% on a QoQ basis from 0.13 in Q4 2025.
Mannkind (MNKD) has 17 years of Debt Ratio data on file, last reported at 0.14 in Q1 2026.
- Quarterly Debt Ratio fell 45.21% year-over-year to 0.14 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.14 (down 45.21% YoY) and the FY2025 annual result came in at 0.13, down 50.53% from the prior year.
- Debt Ratio improved to 0.14 in Q1 2026 per MNKD's latest filing, from 0.13 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.26 in Q4 2024 and bottomed at 0.03 in Q3 2023.
- The 5-year median for Debt Ratio is 0.19 (2023), against an average of 0.16.
- The widest annual swing landed in 2024, when Debt Ratio soared 731.82%; it then sank 50.53% in 2025.
- Tracing MNKD's Debt Ratio over 5 years: stood at 0.03 in 2022, then surged by 632.72% to 0.22 in 2023, then grew by 20.46% to 0.26 in 2024, then slumped by 50.53% to 0.13 in 2025, then rose by 6.18% to 0.14 in 2026.
- Per Business Quant, the three latest MNKD Debt Ratio figures stand at 0.14 (Q1 2026), 0.13 (Q4 2025), and 0.17 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.18 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 1.41 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.05 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 0.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.14 |
| Dec 31, 2025 | 0.13 |
| Sep 30, 2025 | 0.17 |
| Jun 30, 2025 | 0.25 |
| Mar 31, 2025 | 0.25 |
| Dec 31, 2024 | 0.26 |
| Sep 30, 2024 | 0.22 |
| Jun 30, 2024 | 0.23 |
| Dec 31, 2023 | 0.22 |
| Sep 30, 2023 | 0.03 |
| Jun 30, 2023 | 0.03 |
| Dec 31, 2022 | 0.03 |
| Jun 30, 2021 | 0.02 |
| Mar 31, 2021 | 0.02 |
| Dec 31, 2020 | 0.04 |
| Sep 30, 2020 | 0.01 |
| Jun 30, 2020 | 0.02 |
| Jun 30, 2019 | 0.99 |
| Mar 31, 2019 | 0.83 |
| Dec 31, 2018 | 0.77 |
| Sep 30, 2018 | 1.90 |
| Jun 30, 2018 | 1.77 |
| Mar 31, 2018 | 1.87 |
| Dec 31, 2017 | 1.57 |
| Sep 30, 2017 | 2.44 |
| Jun 30, 2017 | 1.73 |
| Mar 31, 2017 | 1.42 |
| Dec 31, 2016 | 1.13 |
| Sep 30, 2016 | 1.25 |
| Jun 30, 2016 | 0.90 |
| Mar 31, 2016 | 1.34 |
| Dec 31, 2015 | 0.98 |
| Sep 30, 2015 | 0.44 |
| Jun 30, 2015 | 0.35 |
| Mar 31, 2015 | 0.34 |
| Dec 31, 2014 | 0.31 |
| Sep 30, 2014 | 0.21 |
| Jun 30, 2014 | 0.37 |
| Mar 31, 2014 | 0.22 |
| Dec 31, 2013 | 0.47 |
| Sep 30, 2013 | 0.42 |
| Dec 31, 2012 | 0.48 |
| Sep 30, 2012 | 1.06 |
| Jun 30, 2012 | 0.91 |
| Mar 31, 2012 | 1.13 |
| Dec 31, 2011 | 1.39 |
| Sep 30, 2011 | 1.24 |
| Jun 30, 2011 | 1.06 |
| Dec 31, 2010 | 0.85 |